Rationale: p38 is an important stress activated protein kinase involved in gene regulation, proliferation, differentiation, and cell death regulation in heart. p38 kinase activity can be induced through canonical pathway via upstream kinases or by noncanonical autophosphorylation. The intracellular p38 kinase activity is tightly regulated and maintained at low level under basal condition. The underlying regulatory mechanism for canonical p38 kinase activation is well-studied, but the regulation of noncanonical p38 autophosphorylation remains poorly understood. Objective: We investigated the molecular basis for the regulation of noncanonical p38 autophosphorylation and its potential functional impact in cardiomyocytes. Methods and Results: Using both proteomic and biochemical tools, we established that heat shock protein (Hsp)90-Cdc37 chaperones are part of the p38␣ signaling complex in mammalian cells both in vitro and in vivo. The Hsp90-Cdc37 chaperone complex interacts with p38 via direct binding between p38 and Cdc37. Cdc37 expression is both sufficient and necessary to suppress noncanonical p38 activation via autophosphorylation at either basal state or under TAB1 (TAK1 binding protein-1) induction. In contrast, Cdc37 expression has no impact on p38 activation by canonical upstream kinase MKK3 or oxidative stress. Furthermore, Hsp90 inhibition results in p38 activation via autophosphorylation, and p38 activity contribute to apoptotic cell death induced by Hsp90 inhibition. Conclusion: Our study has revealed a so far uncharacterized function of Hsp90-Cdc37 as an endogenous regulator of noncanonical p38 activity. (Circ Res. 2010;106:1404-1412.)
O xidative stress, proinflammatory cytokines and many other extracellular stimuli activate intracellular stress responses through stress signaling pathways, including SAPK (stress-activated protein kinase) p38 as a member of the mitogen-activated protein kinase (MAPK) superfamily. [1] [2] [3] [4] [5] Although the role of p38 in heart remains controversial, activation of p38 in response to ischemia/reperfusion has been demonstrated repetitively. Several findings suggest p38␣ contributes to myocyte cell death by promoting production of proinflammatory cytokines including tumor necrosis factor (TNF)␣, interleukin (IL)-1, and IL-8. This is also supported by the protective effect of p38-specific inhibitor SB203580 in ischemia. On the other hand, protective effect of p38 through activation of heat shock protein (Hsp)27 has also been suggested. There are 2 modes of p38 activation in ischemia. One is the canonical p38 pathway, which is activated by a cascade of phosphorylation through upstream MEKKs (MAPK/extracellular-activated kinase kinases) such as Ask1, 6 and MAPK kinase (MKK)3, -4, or -6, leading to phosphorylation of the TGY motif within the p38 activation loop. 3, 4, 7 In addition, noncanonical MKK-independent activa-tion of p38 has been demonstrated through intrinsic autophosphorylation 8, 9 that can be facilitated by direct interaction with TAB1 or ZAP-70. It has been speculated that these 2 different pathways are activated by different stimuli, and contribute differently to regulate p38 functions in response to ischemia/reperfusion.
The canonical p38 activation is a highly regulated process involving well-studied upstream kinases (MKKs) and protein phosphatases (MKPs) (PP2C␣/␤) as its positive and negative regulators respectively. 10 -12 In contrast, the regulatory mechanism for noncanonical p38 pathway remains poorly understood. Autophosphorylation is an intrinsic property of p38 kinase, 8, 9 and although TAB1 and ZAP-70 are reported to function as positive inducers of p38 autophosphorylation, [13] [14] [15] [16] the molecular mechanism in its negative regulation remains unclear. It is important to note that p38 activity is maintained at low level in cells in the absence of stress stimulus, suggesting that autophosphorylation activity of p38 is normally suppressed at the basal state.
In this study, we identified Hsp90-Cdc37 chaperone complex as a specific component of p38 kinase signaling com-plex. Hsp90 constitutes 1% to 2% of cellular proteins 17 to regulate the stability and the activity of its client proteins, 18 including protein kinases. 19 -23 In most cases, Hsp90 functions to stabilize its client protein kinases and promotes kinase activation. The loss of prosurvival kinases at both protein and activity levels are implicated as a major mechanism underlying the anticancer effects of Hsp90 inhibitors. Based on the evidence that p38 protein level is not affected by Hsp90 inhibition, earlier reports have classified p38 as a nonclient protein of Hsp90. 24 -26 Using biochemical and molecular approaches, we have shown both in vitro and in vivo that p38 specifically interacts with Hsp90 chaperone through direct binding to its cochaperone Cdc37. Recombinant Hsp90-Cdc37 is sufficient to attenuate autophosphorylation of recombinant p38 kinase in an Hsp90 activity dependent manner. Furthermore, Cdc37 is both sufficient and necessary for suppressing basal p38 activity, and exogenous Cdc37 expression suppresses noncanonical p38 activation via TAB1 but has no impact on canonical p38 activation via MKK3. In cultured cardiomyocytes, inhibition of Hsp90 leads to rapid p38 autophosphorylation, which contributes to apoptotic cell death resulted from Hsp90 inhibition. In conclusion, we establish, for the first time, that p38 is a bona fide client protein of Hsp90-Cdc37 chaperone complex. Hsp90-Cdc37 is essential to specifically suppress noncanonical autophosphorylation of p38, although it has no impact on canonical p38 activation. Therefore, Hsp90-Cdc37 represents the first identified noncanonical pathway-specific negative regulator for p38. This finding is a potentially important addition to the mechanistic repertoire for the diverse function of Hsp90 as a master signaling modulator.
Methods

Immunoprecipitation
Recombinant proteins were cloned from ventricular cDNA library prepared using SSII RT and oligo dT primer according to the protocol of the manufacturer (Invitrogen). Precipitated proteins (0.1 to 0.3 g) were mixed into binding buffer, and incubated at 4°C in the presence of anti-Cdc37 (Abcam) and Protein A (GE Healthcare) for 3 hours. Anti-FLAG M2 affinity gel (Sigma) was used for FLAG co-IP, and the experiment was conducted according to the protocol of the manufacturer.
Kinase Assay
Kinase assay was carried out following a protocol provided by Cell Signaling. Briefly, 0.3 g of GST recombinant proteins were mixed in kinase assay buffer, with or without 5 mol/L SB203580 or 10 mol/L GA. For a detection of de novo phosphorylation, 5 Ci of ␥-P32-ATP was included. Mixtures were incubated for 15 minutes at 30°C, and iced immediately. Phosphorylation was detected by autoradiography.
Short Hairpin RNA-Mediated Cdc37 Knockdown
shCdc37 was cloned into pSuper. Its efficacy was verified, and pSuper-shCdc37 was digested with PacI and cloned into pAdEasy through homologous recombination to produce Adv-shCdc37.
TUNEL Staining
Cells were grown on laminin coated glass coverslips, fixed in 2% paraformaldehyde, and permeabilized in 1% Triton X-100, 1% sodium citrate solution. TUNEL staining was carried out using ApopTag Peroxidase in situ Apoptosis Detection Kit (Chemicon International) according to the protocol of the manufacturer. Apoptotic occurrence was determined by counting TUNEL-positive cells, which colocalize with DAPI (4Ј,6-diamidino-2-phenylindole) staining, and dividing by the total number of nucleus. Statistical significance was determined by Student t test.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results
Identification of HSP90-Cdc37 in Cardiac p38␣ Complex
We and others have reported that p38 activation in heart has a number of pathological consequences. 1, 14, [27] [28] [29] To study the molecular mechanisms of p38 regulation and function in heart, p38␣ protein complex was isolated through coimmunoprecipitation (co-IP) from transgenic mouse heart expressing N-terminally FLAG-tagged dominant negative p38␣ (FLAG-DNp38␣). We used DNp38␣ instead of wild-type p38␣ (WTp38␣) because p38 phosphorylation, as well as the interaction between WTp38 and many of its binding partners are relatively transient. 13 The molecular identities of the p38 signaling complex was established by liquid chromatography-tandem mass spectrometric analysis with Ͼ95% confidence and are summarized in Online Table I. In addition to known p38 interacting proteins, Hsp90␣, Hsp90␤, and cochaperone Cdc37 were identified with significant peptide coverage ( Figure 1A) . The presence of Hsp90␣/␤ and Cdc37 in the p38␣ complex was confirmed by Western immunoblots ( Figure 1B) . As a control for specificity, another known Hsp90 cochaperone, Hsc70 was not detected. 30 To determine whether p38␣ and Hsp90-Cdc37 complex interact directly, we performed co-IP using recombinant proteins. As shown in Figure 1C , Hsp90 interacts much stronger with FLAG-DNp38␣ in the presence of Cdc37, with Hsp90␤ showing a higher affinity than Hsp90␣. In contrast, Cdc37 was able to interact with either WT or DN of p38␣ in the absence of Hsp90 ( Figure 1D ). Therefore, p38␣ appears to bind directly to Cdc37, which can subsequently recruit p38␣ into Hsp90-Cdc37 complex, a scheme previously demonstrated for other Hsp90-Cdc37 client protein kinases. 17, 31 Consistently, p38 and Hsp90-Cdc37 in total protein extract prepared from heart tissue had broad distribution pattern on a sucrose gradient with significant overlap (Online Figure I, A) . However, when the p38 immunocomplex was isolated from heart and separated on the same sucrose gradient, Hsp90 was detected only in the same fractions when both Cdc37 and p38 were present, whereas a separate pool of p38 and Cdc37 comigrated together without Hsp90 (Online Figure  I, B ). All of these findings suggest that p38 specifically interacts with Hsp90-Cdc37 complex via direct binding with Cdc37.
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Molecular Basis of Interaction Between p38␣ and Cdc37
To determine the Cdc37 binding domain on p38␣, we created a number of GST-tagged truncation mutants of p38␣ and performed co-IP assays with Cdc37 ( Figure 2A ). The results indicated that the N terminus of p38␣ contains a putative Cdc37 binding motif. Based on the sequence analysis, p38 MAPK isoforms share a common GXGXYG motif at their N terminus, which is reported to function as an ATP binding site, 32 whereas c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) have GXGXQG and GXGXPG, respectively. Interestingly, GXGXF/YG is reported as a conserved Cdc37 binding site. 23 However, Y35A single mutation or Y35A and G31A double mutations on p38␣ did not abolish its binding to Cdc37; instead, the GY double mutant appeared to bind Cdc37 stronger ( Figure 2B ). The VIWCI residues within the Hsp90-binding motif of Cdc37 are also reported to be critical for binding of another established client protein kinase Raf-1. 33 However, Cdc37 protein with mutation at V192A or both V192A and I193A had similar p38␣ binding capacity as the Cdc37WT ( Figure  2C ). Therefore, the direct interaction between N-terminal The total numbers of identified peptide sequences (Queries Matched), total number of identified peptides (Peptide Matched), the percentage of sequence covered by the identified peptides (Coverage %), and peptide mass spectra fingerprinting score based on MASCOT database (MOWSE, Ͼ40 indicates a significant match) are shown. B, Immunoblots on immunocomplex isolated with anti-FLAG antibody (IP: FLAG) from DNp38␣ transgenic (TG) and nontransgenic (NTG) control hearts using antibodies as labeled. C, Co-IP using purified recombinant proteins with anti-FLAG after incubating FLAG-DNp38␣ protein with GST-Cdc37, GST-Hsp90␣, and GST-HSP90␤ as indicated, followed by immunoblots with anti-GST, antip38␣, anti-Cdc37, and anti-Hsp90␣/␤. Only small-molecular-mass section containing GST (28KD) was shown for the GST blots. Note the GST signal from lane 2 of the input panel is from the breakdown product of GST-Hsp90␣. D, IP with anti-Cdc37 after incubating recombinant GST-Cdc37 with GST-DNp38␣, GST-p38␣, or GST alone as a control, followed by immunoblot using anti-Cdc37, antip38␣, and anti-GST as indicated. Only small-molecular-mass section containing GST (28 kDa) was shown for the GST blots. Note the GST signals from lanes 1 and 2 of the input panel are from the breakdown product of GST-p38.
Figure 2. Specific interaction between
Cdc37 and p38␣. A, IP with anti-Cdc37 after incubating Cdc37 with GST-tagged truncated p38␣ as labeled, followed by immunoblots with anti-GST and anti-Cdc37 as indicated. All the experiments were repeated at least 3 times. B, Purified recombinant p38␣ (0.1 g) with Y35A (Y) or Y35A and G31A (GY) mutations were subjected to co-IP with Cdc37 using anti-Cdc37 and analyzed by immunoblots as indicated. C, Cdc37 with single mutation at V131A (Cdc37 V) or double mutations at V192A and I193A (Cdc37 VI) were mixed with recombinant WT-or DN-p38␣ and immunoprecipitated using anti-Cdc37, followed by immunoblots as indicated.
domain of p38␣ and Cdc37 appears to be mediated by so far uncharacterized motifs.
Hsp90-Cdc37 Chaperone Directly Inhibits p38 Autophosphorylation In Vitro
To investigate the functional implication of Hsp90-Cdc37 interaction with p38, we first performed in vitro phosphorylation assay using recombinant p38␣ and the isolated p38␣ immunocomplex, but we did not detect de novo phosphorylation at the molecular weight of Hsp90 or Cdc37 (Online Figure II ), suggesting that Hsp90 and Cdc37 are unlikely the direct substrates of p38␣. To examine whether Hsp90-Cdc37 chaperone complex is able to directly regulate p38␣ kinase activity, in vitro phosphorylation assay was performed using purified recombinant proteins ( Figure 3 ). As reported previously, 34, 35 we observed SB203580-sensitive autophosphorylation of recombinant p38␣ before coincubation with Cdc37-Hsp90␣/␤ (Ϫincubation). However, overnight incubation with recombinant Cdc37 and Hsp90␣/␤ before the kinase assay resulted in a marked decrease in SB203580-sensitive autophosphorylation of p38␣ (ϩincubation). Such inhibition of p38␣ autophosphorylation by Hsp90-Cdc37 was blocked by the addition of Hsp90 inhibitor geldanamycin (GA) during the kinase assay. Therefore, Hsp90-Cdc37 chaperone complex appears to be responsible for inhibiting p38␣ autophosphorylation without other cellular proteins and this inhibitory function is chaperone activity dependent.
Hsp90-Cdc37 Inhibits p38 Autophosphorylation In Vivo
Our data suggest that Hsp90-Cdc37 may function to suppress the autophosphorylation of endogenous p38 kinase in cells. However, it is well established that Hsp90 also regulates the stability and the activity of many of its client kinases via ATP dependent chaperone activity. 36 -39 As shown in Figure 4A , treatment with GA resulted in a robust induction of p38 activity within 5 minutes, which lasted for the duration of the experiment without significant change in the total protein level of p38 ( Figure 4A ). In contrast, at 5 minutes after GA treatment, activities of upstream MKK3/6 and other MAPK pathways including ERK and JNK were not affected. At later time points, JNK activity was also induced to a modest level, along with phospho-Hsp27, a downstream target of p38, whereas ERK activity remained unaffected. Activation of p38 phosphorylation was also observed using 17-AAG (17allylamino-17-demethoxygeldanamycin) as an alternative Hsp90 inhibitor (Online Figure III, A) . . Impact of Hsp90 inhibition on p38 activity. A, NRVMs were treated with 1.8 mol/L GA for different time periods in minutes as indicated. Immunoblots for total protein lysates collected from duplicate samples at each time point are shown using specific antibodies as labeled. NRVMs treated with equal volume of DMSO and IL-1␤ were included as basal and positive controls for p38 activation respectively. B, NRVMs were preincubated with 1 mol/L SB203580 or DMSO for 20 minutes before 1.8 mol/L GA treatment for different time periods. Immunoblots were performed from the total protein lysates using antibodies as labeled. C, p-p38 level normalized to background level was quantified for NRVMs treated with DMSO, GA, and GAϩSB for 5 minutes (nϭ5; *PϽ0.05, **PϽ0.005). D, MKK3/6 DKO MEFs (DKO) were pretreated with 1 mol/L SB203580 for 30 minutes, followed by 1.8 mol/L GA or 0.01% DMSO for another 30 minutes. Immunoblots on the total cell lysates was performed with antibodies as indicated. Nontreated WT MEF (ϩ) was run on the side as a positive control for the immunoblots. E, p-p38 level normalized to background level was quantified for DKO MEF treated with DMSO, GA, and GAϩSB for 30 minutes (nϭ4; *PϽ0.05, **PϽ0.001).
Addition of p38 inhibitor SB203580 along with GA effectively diminished early induction of p38 phosphorylation, a characteristic feature of p38 kinase autophosphorylation. After longer GA treatment, an increase in phospho-MKK4 was observed, and the level of p38 phosphorylation became less sensitive to SB203580, suggesting an increased contribution of canonical p38 activation at later time points, perhaps attributable to secondary and nonspecific effects of Hsp90 inhibition. Phospho-p38 level in the presence or absence of GA and SB203580 were also quantified to demonstrate the SB-sensitive activity of p38 in neonatal rat ventricular myocytes (NRVMs) ( Figure 4C ). Furthermore, GA-induced autophosphorylation was observed in the MKK3/6 DKO MEFs ( Figure 4D and 4E) , again supporting MKK-independent activation of p38. In agreement with this scheme, T180 but not Y182 of p38 was selectively phosphorylated at 5 minutes after GA treatment, whereas only slight increase in phospho-Tyr-p38 was observed 15 minutes after GA treatment (Online Figure IV, A) . Furthermore, HeLa cells expressing p38␣T180A showed blunted response to GA, further supporting the notion that T180 is the site for GA induced p38 autophosphorylation (Online Figure IV, B) .
To investigate the impact of p38 activation status on its interaction with Hsp90/Cdc37, we studied endogenous p38 kinase interaction with Cdc37 in HeLa cells which also demonstrated GA induced p38 autophosphorylation ( Figure  5A ). On Hsp90 inhibition, total p38 protein in the Cdc37 immunocomplex was reduced relative to the untreated cells, whereas phospho-p38 was not detected in Cdc37 immunocomplex under either basal or stimulated conditions ( Figure  5B ). This observation suggests that Hsp90-Cdc37 preferentially interacts with nonphosphorylated p38 and Hsp90 inhibition promotes p38 autophosphorylation associated with its release from the Hsp90-Cdc37 complex.
Cdc37 Expression Is Both Sufficient and Necessary for Regulating Basal p38 Activity
From these biochemical studies, we can speculate that Hsp90-Cdc37 chaperone complex is a negative regulator for basal p38 activity. To demonstrate the functional significance of Hsp90-Cdc37-mediated regulation of basal p38 activity, we used 2 different Adv-shCdc37 constructs to achieve selective knockdown of Cdc37 in HeLa cells. As shown in Figure 6A , Cdc37 short hairpin RNA (shCdc37) expression resulted in a dosage dependent decrease in Cdc37 protein level in parallel with an increase in phospho-p38. Knockdown of Cdc37 protein also reduced p38 interaction with Hsp90 based on co-IP assay (Online Figure V) . On the other hand, overexpression of Cdc37 in HeLa cells significantly reduced the Figure 5 . Impact of Hsp90 inhibition on p38 activity and interaction with Cdc37 in HeLa cells. A, Immunoblots for phosphoand total p38 on HeLa cells treated with 1.8 mol/L GA for time periods, as indicated in the presence of absence of pretreatment with 1mol/L SB203580. B, Co-IP assay on HeLa cell extract with or without 1.8 mol/L GA treatment for 15 minutes. Immunoprecipitation with anti-Cdc37 was followed by immunoblots with antibodies as indicated. Relative intensity of the signals of total p38, Cdc37, and Hsp90 in the elution blots were quantified and shown in a bar graph. Figure 6 . Functional impact of Cdc37 expression on canonical and noncanonical p38 activation. A, HeLa cells were infected with different multiplicities of infection (0 to 500) of adenoviral vectors expressing scramble or 2 different shCdc37 constructs (shCdc37-1 and shCdc37-2) for 48 hours. Immunoblots for Cdc37, phospho-p38, and total p38 were performed using specific antibodies as indicated. ␤-Actin was used as a loading control. B, HeLa cells were transfected with vector or Myc-Cdc37 for 24 hours, followed by treatment with 1.8 mol/L GA for 15 minutes with or without 1 mol/L SB203580 added 20 minutes before the GA treatment. Immunoblots for Cdc37, phospho-, and total p38, as well as phospho-and total JNK, were performed as indicated. C, HeLa cells were transfected with constitutively active MKK3 (MKK3bE) with or without Cdc37 and treated with 1 mol/L SB203580 for 30 minutes. Immunoblots for p38 and its downstream substrates are shown as indicated. D, Cdc37 was expressed in HeLa cells with TAB1␤. Immunoblots are shown with ␤-actin as a control.
basal p38 activity and blocked p38 autophosphorylation induced by GA ( Figure 6B ). Therefore, it appears that Hsp90-Cdc37 chaperone complex is both necessary and sufficient to regulate the basal activity of endogenous p38 by negatively suppressing its autophosphorylation. However, the elevated basal p38 activity in Cdc37 knock-down cells was no longer very sensitive to p38 inhibition ( Figure 4B ). The underlying reason is unclear but may be partially attributable to toxicity inflicted by Lipofectamine treatment.
Hsp90-Cdc37 Specifically Regulates Noncanonical p38 Pathway Without Significant Impact on Canonical p38 Activation
Using H 2 O 2 as an established p38 inducer via canonical pathway, we observed that overexpression of Cdc37 did not have a significant effect on p38 activation and its downstream signaling induced by H 2 O 2 , suggesting that Hsp90-Cdc37 complex has no impact on canonical p38 pathway (Online Figure VI) . To study this further, HeLa cells were cotransfected with constitutively active MKK3 (MKK3bE) and Cdc37. As expected, MKK3bE led to a significant induction of phospho-p38 in the presence or absence of p38 inhibitor ( Figure 6C ). However, coexpression of Cdc37 did not affect p38 induction by MKK3bE, suggesting that canonical p38 activation pathway is not affected by Cdc37 ( Figure 6C ).
It has been shown that TAK1 binding protein-1 (TAB1) promotes autophosphorylation of p38␣ through direct interaction. 13 Consistently, expression of TAB1␤, which lacks the TAK1 binding domain, 15 was sufficient to induce p38 activation in HeLa cells ( Figure 6D ). To determine whether Cdc37 can regulate TAB1␤ mediated autophosphorylation of p38, Cdc37 and TAB1␤ were coexpressed in HeLa cells ( Figure 6D) . The results showed that the p38 activation by TAB1␤ was reduced by the exogenous Cdc37, suggesting that Cdc37 overexpression can negatively regulate p38 autophosphorylation induced by TAB1␤. Together with the previous results, our data indicate that Hsp90-Cdc37 chaperone complex selectively regulates the noncanonical p38 activation pathway, but not the MKK-dependent canonical activation pathway.
Role of p38 in Hsp90-Cdc37 Inhibition Induced Cardiomyocyte Apoptosis
Hsp90 is reported to have a potent cytoprotective function in the heart. 40 -42 As expected, treating NRVMs with Hsp90 inhibitor GA resulted in massive cell death within 6 hours ( Figure 7A ). Consistent with the increased cell death, the expression levels of both IL-6 and TNF␣ were increased in NRVMs treated with GA (Online Figure VII) . Similarly, COS7 cells treated with GA showed a significant increase in TUNEL-positive apoptotic cells ( Figure 7B ). However, the relative low frequency of TUNEL ϩ cells (1.1%) suggest that apoptosis may not be the only cause to trigger massive cell death induced by GA. Consistent with its effect on p38 autophosphorylation, 17-AAG treatment also led to similar cell death though to a lesser extent (Online Figure III, B) . Expression of DN38␣ was sufficient to block p38 dependent downstream signaling as demonstrated by the reduced p-Hsp27 and p-MK2 ( Figure 7C ). DNp38␣ expression in NRVMs significantly delayed GA induced cell death up to 12 hours ( Figure 7D) . The reduction in cell death by DNp38␣ correlated with a decrease in the level of TUNEL-positive cells, suggesting that p38 activation contributed to GA induced apoptosis ( Figure 7E ). The loss of efficacy of DNp38␣ in suppressing apoptosis at higher dose of GA treatment (9 mol/L) also suggests that the contribution of p38 activation in HSP90-mediated cell death regulation is partial. This is consistent with the earlier data which shows delayed, but not complete inhibition of cell death in the presence of DNp38␣.
Discussion
In this report, we have demonstrated that Hsp90-Cdc37 chaperone complex is a part of the cardiac p38 signaling Hsp90 and p38 activity in myocyte survival. A, NRVMs was treated with 9 mol/L GA or DMSO as a control. Representative images of cell viability were recorded at 0, 6, and 24 hours after treatment as indicated. B, TUNEL staining on COS7 treated with 9 mol/L GA for 6 hours. Quantification of TUNEL-positive cells from 3 different experiments. *PϽ0.01, Student's t test. C, NRVMs were infected with adv-LacZ or Adv-DNp38␣ (DN) for 48 hours, followed by 9 mol/L GA treatment for specific periods as indicated. Immunoblots for phospho-and total p38 were performed. Phospho-MK2 and phospho-Hsp27 were assessed as p38 downstream activities. D, COS7 cells were infected with Adv-LacZ or Adv-DNp38␣ as indicated for 48 hours before treatment with 9 mol/L GA for 0, 12, and 24 hours. Representative images of cell viability are shown at 0, 12, and 24 hours after treatment as indicated. E, Quantification of TUNEL-positive apoptotic COS7 cells among different treatment groups (LacZ vs DNp38␣) at 2 doses of GA (3.6 mol/L vs 9 mol/L) as indicated. *PϽ0.05. complex via direct interaction between p38 and Cdc37. Recombinant Hsp90 and Cdc37 are sufficient to attenuate the intrinsic autophosphorylation activity of the recombinant p38 kinase in test tubes. In intact myocytes, Hsp90 inhibition or Cdc37 knockdown leads to significant induction of p38 autophosphorylation. Cdc37 is both sufficient and necessary to regulate the basal p38 activity, as well as Hsp90 inhibitionor TAB1␤-mediated p38 autophosphorylation, whereas p38 activation induced by H 2 O 2 or MKK3 is not hindered. Finally, p38␣ activity contributes to cell death induced by Hsp90 inhibition in cultured cardiomyocytes or COS cells. These data lead us to conclude that Hsp90-Cdc37 chaperone complex is a specific regulator of noncanonical pathway for p38␣ by suppressing basal autophosphorylation.
Among its vast variety of client proteins, Hsp90 is known to regulate both protein stability and activity of its target kinases. 43, 44 Early studies attempting to identify Hsp90 client kinases by assessing protein degradation in response to Hsp90 inhibition have excluded p38 MAPK as an Hsp90 client kinase based on the observation that p38 kinase protein level was not affected. Yet, increases in p38 phosphorylation in response to Hsp90 inhibition has been reported, 45 and Hsp90 has also been shown to promote autophosphorylation of some of the client protein kinases, such as GSK-3␤. 46 p38 homolog in Schizosaccharomyces pombe, Spc1, is reported to directly bind to yeast Cdc37, 47 and Cdc37 has been suggested to modulate kinase activity independent of Hsp90. 48 The data reported here from both in vitro and cellular experiments clearly demonstrate that mammalian Hsp90 also interacts with p38 through Cdc37. Hsp90 activity is not required for p38 protein stability as no change in the total p38 protein level was observed up to 6 hours of Hsp90 inhibition. Rather, Hsp90-Cdc37 complex functions to suppress p38 autophosphorylation. This finding not only adds p38 kinase to the list of Hsp90 client proteins but also reveals a novel function of the Hsp90-Cdc37 chaperone complex as a negative regulator of kinase autophosphorylation to the established large repertoire of Hsp90-Cdc37 functions. This newly identified mechanism may have general implications in other unidentified Hsp90-Cdc37 client protein kinases that also possess intrinsic autophosphorylation properties.
Although we have demonstrated that Cdc37 directly binds to p38␣ both in vitro and in vivo, the underlying molecular basis is unclear. It appears that the N-terminal domain of p38␣ contains weak Cdc37 binding activity when it is expressed in its truncated form, but mutations within a putative Cdc37 binding motif (GXGXYG) failed to disrupt full-length p38␣ interaction with Cdc37. Indeed, GY double mutant appeared to bind stronger to Cdc37 ( Figure 2B ), suggesting that protein conformation in the N-terminal domain, which is known to go through conformational change on autophosphorylation, may be involved in this interaction. 8, 35 Likewise, although Cdc37 is reported to require V192 and I193 residues 33 to interact with a client protein kinase Raf-1, mutations of these sites did not affect its p38␣ interaction. Clearly, more efforts are needed to identify the responsible motifs involved in p38␣-Cdc37 interaction.
Autophosphorylation is an intrinsic property of p38 kinase, although its physiological role remains uncertain. 8, 9 TAB1 and ZAP-70 are reported to positively promote p38 autophosphorylation thus represent a noncanonical pathway for p38 activation under different upstream stimuli with different functional outcome. [13] [14] [15] [16] Previous studies have revealed much of the regulatory components for canonical p38 pathway, including upstream MKKs, downstream targets and negative modulating phosphatases. 10 -12 However, the regulatory components specific for the noncanonical pathway remain elusive. Our report here has provided the first evidence that Cdc37 expression has no impact on p38 activation induced by H 2 O 2 or MKK3, but significantly attenuates TAB1-mediated autophosphorylation of p38, suggesting that Hsp90-Cdc37 chaperone complex is a noncanonical pathway-specific regulator for p38. The molecular basis for this specificity is unclear. We showed that phosphorylated p38 was not detectable in the Hsp90-Cdc37 immunocomplex and the total p38 protein present in the Hsp90-Cdc37 complex was reduced on Hsp90 inhibition. This observation suggests that phosphorylated p38 loses the ability to bind to Cdc37. Thus, we can speculate that p38 autophosphorylation is inhibited by Hsp90-Cdc37 by conferring a change in p38 protein conformation. Although this change does not affect its recognition and phosphorylation by upstream kinases, it hinders p38 autophosphorylation induced by noncanonical activator, such as TAB1.
Hsp90 inhibition induced cell death is an emerging therapeutic strategy to treat cancer and the underlying mechanisms mainly involve the loss of prosurvival proteins, such as AKT, Raf-1, Cdk4, and p53. 49, 50 Our data suggest that activation of p38 via autophosphorylation may also play a significant role in Hsp90 inhibition induced cell death accompanied by increased expression of inflammatory cytokines including IL-6 and TNF␣, thus providing yet another possible downstream mechanism in Hsp90-mediated cell death regulation. Although our data suggest Hsp90 inhibition induced cell death involves apoptosis, other forms of cell death, including necrosis and autophagy, cannot be excluded. The full scope of both physiological and pathological role of Hsp90-Cdc37 complex in p38-mediated stress signaling remains to be determined. However, autophosphorylation of p38 in response to ischemia and its contribution to cardiac injury have been reported. Ischemia/reperfusion on MKK3 Ϫ/Ϫ heart demonstrated TAB1-mediated autophosphorylation of p38, which appeared to play a role in necrosis of cardiomyocytes. 14 Autophosphorylated p38 was also reported to mediate glucose uptake through GLUT4 induced by ischemia 51 and TAB1-p38 interaction was implicated in myocyte apoptosis regulation by cGMP-depending kinase I. 52 On the other hand, Hsp90 inhibition exacerbated cardiac injury induced by doxorubicin, a known p38 activator in heart 53 and overexpression of Hsp90 protected ischemia/reperfusion injury in heart. 54 Therefore, it can be speculated that Hsp90-Cdc37mediated p38 autophosphorylation may play a role in ischemia/reperfusion injury in heart. Our data in Online Figure VII show a significant induction of inflammatory cytokines by Hsp90 inhibition in NRVMs, suggesting that Hsp90-Cdc37mediated noncanonical p38 activity may have different downstream effect versus TAB1-mediated activation in heart which does not appear to induce inflammatory gene induc-tion. 15 Our data also suggest the presence of numerous sarcomere-associated proteins in cardiac p38 complex (Online Table I ), yet their functional relevance to Hsp90-Cdc37mediated p38 activity remains unknown. Further studies with targeted manipulation of Hsp90-Cdc37-p38 interaction will be needed to fully establish the functional relevance of this new stress signaling pathway.
Other than chaperone function, Hsp90 can also serve as a scaffold protein to coordinate/integrate multiple signal transduction activities in different cellular processes. 55 We and others have demonstrated in previous studies that cardiac p38 kinase also functions to regulate diverse cellular processes including gene transcription, 7 proliferation, 56 apoptosis, 6, 57 and cardiac contractility. 58, 59 Canonical and noncanonical pathways for p38 activation can have major differences in intracellular localization, downstream targets, and ultimate functional outcome. 15 In short, identification of Hsp90-Cdc37 as an additional component in noncanonical p38 signaling pathway will help to elucidate the molecular network and intricate regulatory mechanisms for this important stress signal pathway.
